首页> 外文期刊>Journal of enzyme inhibition and medicinal chemistry. >Synthesis and antimicrobial studies of novel 2,4-diaryl-3-azabicyclo[3.3.1]nonan-9-one 4′-phenylthiosemicarbazones
【24h】

Synthesis and antimicrobial studies of novel 2,4-diaryl-3-azabicyclo[3.3.1]nonan-9-one 4′-phenylthiosemicarbazones

机译:新型2,4-二芳基-3-氮杂双环[3.3.1] nonan-9-one 4'-苯基硫代半脲酮的合成与抗菌研究

获取原文
           

摘要

New series of 2,4-diaryl-3-azabicyclo[3.3.1]nonan-9-one 4′-phenylthiosemicarbazones (compounds 9–16) was obtained from the corresponding 2,4-diaryl-3-azabicyclo[3.3.1]nonan-9-ones. The synthesized compounds have been characterized by their elemental, analytical, and spectral studies. Besides, these reported compounds were screened for their antibacterial and antifungal activities against a spectrum of microbial organisms. These studies proved that against bacteria, compounds 10 and 11 against Bacillus subtilis, compound 13 against Salmonella typhi, show maximum inhibition potency at low concentration (6.25 μg/mL), whereas against fungal, compounds 11, 13, and 16 against Candida albicans and compounds 12 and 13 against Cryptococcus neoformans, showed beneficial antifungal activity at minimum concentration (6.25 μg/mL).
机译:从相应的2,4-二芳基-3-氮杂双环[3.3.1]获得了一系列新的2,4-二芳基-3-氮杂双环[3.3.1]壬南-9- 1'4'-苯基硫代半咔唑酮(化合物9–16)。 ] nonan-9-ones。合成的化合物已通过其元素,分析和光谱研究进行了表征。此外,还对这些报道的化合物针对各种微生物的抗菌和抗真菌活性进行了筛选。这些研究证明,针对细菌,针对枯草芽孢杆菌的化合物10和11,针对伤寒沙门氏菌的化合物13,在低浓度(6.25μg/ mL)时显示最大的抑制效力,而对于真菌,化合物11、13和16对白色念珠菌和化合物12和13对抗新型隐球菌,在最小浓度(6.25μg/ mL)下显示出有益的抗真菌活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号